Droplex EGFR Mutation Test v2

BIOTYPE GmbH

Dresden, Germany

BIOTYPE is a German in vitro diagnostics and medical device company, headquartered in Dresden, capital city of Saxony. With over 20 years of experience, we develop, manufacture, and distribute products systems for molecular precision diagnostics and analysis of DNA RNA biomarkers. BIOTYPE also provides high-quality and IVD-compliant contract development manufacturing services. Founded in 1999, the company has extensive expertise in providing high-quality technologies, products, and services for molecular diagnostics to professional laboratories, biotech companies, Big Pharma, and MedTech/diagnostics companies worldwide. BIOTYPE offers a strong portfolio in molecular cancer diagnostics for applications in hemato-oncology, liquid biopsy, and molecular profiling of solid tumors. The portfolio includes IVD assays for clinical diagnostics, RUO assays for translational and clinical research, and a benchtop system for automated molecular profiling. The molecular test systems are used by professional laboratories to support accurate diagnoses of cancer patients, selecting the best possible treatment option, and aiding in the timely identification of actionable biomarkers for molecular-guided therapy. BIOTYPE provides its full value chain in molecular test development as services for contract development and contract manufacturing to academic and commercial partners worldwide. All of BIOTYPE's products and services are provided with highest quality standards.